Edition:
India

People: Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

101.05USD
17 Jun 2019
Change (% chg)

$0.02 (+0.02%)
Prev Close
$101.03
Open
$101.13
Day's High
$101.31
Day's Low
$100.97
Volume
16,388
Avg. Vol
291,641
52-wk High
$116.43
52-wk Low
$78.97

Manner, Carrie 

Ms. Carrie Eglinton Manner is Senior Vice President - Advanced Diagnostics of the Company. Ms. Eglinton Manner joined the Company in January 2017. She is responsible for the Company's advanced testing activities, including overseeing the development of clinical franchise solutions in the areas of neurology, oncology and women's health. Previously, Ms. Eglinton Manner spent over 20 years in various leadership roles in healthcare businesses at General Electric. From 2015 to 2016, she served as President and CEO of the Detection and Guidance Solutions business, delivering advanced x-ray technologies spanning the continuum of healthcare. From 2013 to 2015, Ms. Eglinton Manner served as President and CEO of OEC Surgical Mobile C-arm systems. She was President and CEO of General Electric's diagnostic pathology laboratory services business from 2012 to 2013, and President of the Maternal Infant Care Business from 2009 to 2012.

Basic Compensation

Total Annual Compensation, USD 997,998
Restricted Stock Award, USD 900,090
Long-Term Incentive Plans, USD --
All Other, USD 717,447
Fiscal Year Total, USD 2,615,540

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stephen Rusckowski

10,348,000

Mark Guinan

3,460,400

James Davis

3,270,240

Gabrielle Wolfson

--

Michael Prevoznik

2,090,390

Jon Cohen

2,491,990
As Of  31 Dec 2017